文献速递乳房整形与再造

企业付款是否影响乳房手术中脱细胞真皮基质使用相关研究

Do Corporate Payments Influence Research Related to the Use of Acellular Dermal Matrices in Breast Surgery?
PubMed 文献 · Plast Reconstr Surg · 2023-02-27

本研究通过PubMed检索2014年1月至2019年12月四本整形外科期刊中关于乳房手术使用脱细胞真皮基质(ADM)的文章,利用Open Payments数据库确定作者财务利益冲突(COI)。共纳入55篇文章,51篇(92.7%)有第一或资深作者存在COI,有COI作者更常报告阳性结果(P=0.02);阳性结果研究的第一作者获得显著更高付款(95,955美元 vs 15,642美元;P=0.029)。

要点

  • 55篇文章中24篇(43.6%)支持ADM使用,12篇(21.8%)不促进使用,19篇(34.5%)中立。
  • 51篇研究(92.7%)存在第一或资深作者财务利益冲突,有COI作者更常报告阳性结果(P=0.02)。
  • 8名资深作者和3名第一作者从ADM生产商获得超过500美元但未报告任何财务披露。

核心结论

  • 财务利益冲突与研究报告ADM在乳房手术中获益的可能性较高相关;财务利益冲突报告仍不一致,需要更好监管以确保ADM在乳房手术中使用的无偏倚发表。

研究设计与样本

  • 使用PubMed数据库识别2014年1月至2019年12月四本领先整形外科期刊中报告乳房手术使用ADM的文章。
  • 通过Open Payments数据库确定作者财务利益冲突。

主要发现

  • 共纳入55篇文章,其中24篇(43.6%)支持使用ADM,12篇(21.8%)不促进ADM使用,19篇(34.5%)中立。
  • 51篇研究(92.7%)有第一或资深作者存在COI,有COI作者更常报告阳性结果(P=0.02)。
  • 阳性结果研究的第一作者获得显著更大财务付款(95,955美元 vs 15,642美元;P=0.029)相比阴性或中性结果研究。
  • 受试者工作特征曲线显示第一作者获得超过376.28美元的研究更可能报告阳性结果。
  • 8名资深作者和3名第一作者从ADM生产商获得超过500美元但未报告任何财务披露。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No study has assessed the impact of financial conflicts of interests (COIs) on the reporting of breast reconstruction outcomes with acellular dermal matrix (ADM) in peer-reviewed publications. The authors hypothesized that there is (1) an association between financial COIs and likelihood of studies reporting benefits in using ADM, and (2) inconsistent reporting of financial COIs. METHODS: The PubMed database was used to identify articles that reported on the use of ADM in breast surgery in four leading plastic surgery journals from January of 2014 to December of 2019. Financial COIs for authors were determined using the open payments database. RESULTS: Fifty-five articles were included. Twenty-four articles (43.6%) supported use of ADM, 12 (21.8%) did not promote ADM use, and 19 (34.5%) were neutral. Fifty-one studies (92.7%) had either a first or senior author with a COI, and authors with a COI more commonly reported positive outcomes ( P = 0.02). Studies with positive outcomes featured first authors who received significantly larger financial payments ($95,955 versus $15,642; P = 0.029) compared with studies with negative or neutral outcomes. Receiver operating characteristic curve demonstrated that studies with first authors receiving over $376.28 were more likely to report positive results. Eight senior authors and three first authors received greater than $500 from ADM producers yet did not report any financial disclosure. CONCLUSIONS: Financial COI is associated with higher likelihood of studies reporting benefit of using ADM in breast surgery. There remains inconsistent reporting of COIs, and better oversight is needed to ensure unbiased publication on the use of ADM in breast surgery.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Lee ZH, Diep GK, Brydges HT, et al. Do Corporate Payments Influence Research Related to the Use of Acellular Dermal Matrices in Breast Surgery? Plast Reconstr Surg. 2023. PMID: 36827475. doi:10.1097/PRS.0000000000010320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。